Blood clot prevention study for people getting a PICC line
Part of Heart & circulation clinical trials.
This study tests two experimental drugs, REGN7508 and REGN9933, to see if they can safely prevent blood clots in the arm or chest in people who need a PICC line. If you are getting a PICC for treatments like chemotherapy or antibiotics, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to get a PICC line for medicines like chemotherapy, antibiotics, or nutrition
- You are generally able to care for yourself, even if you need some help (ECOG score 0-3)
- Your blood clotting tests (INR and aPTT) are within a safe range
- You weigh at least 88 pounds (40 kg)
- You do not have certain blood cancers (like acute leukemia) or tumors in the digestive or urinary tract that have not been removed
- You do not have a history of clots in the arm or chest where the PICC goes, and you do not have a brain tumor or recent heart problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new anticoagulant medication to treat and prevent blood clots in patients with active cancer. You may qualify if you have a recent clot in your leg or lungs and are already taking a blood thinner.
This trial tests whether a daily injection of a blood-thinning medicine called enoxaparin (Lovenox) can safely prevent dangerous blood clots in teens who are critically ill in the intensive care unit with an IV line and an infection or inflammation. It may help reduce the risk of blood clots without causing excess bleeding.
This study looks at how often people with a blood infection from a PICC or midline catheter also get a blood clot in the vein of their arm. The goal is to learn more about this problem so doctors can better prevent and treat it.
This trial tests whether starting enoxaparin (a blood-thinner) within 24 hours after placing a specific type of central line can prevent dangerous clots. It may help reduce clot risk in people whose line is placed in the neck or thigh vein, while also tracking bleeding side effects.
This trial tests whether continuing a lower dose of blood thinners can prevent another blood clot in cancer patients who have had a clot in an arm or chest catheter. It may help find a safer way to prevent future clots.
This study looks at ways to reduce problems that can happen with a type of long-term IV line called a PICC line. It is for people who are independent and able to care for themselves, and it aims to make managing the line safer and easier.
Hear when a new Venous Thromboembolism (VTE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.